首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1271218

干细胞软骨再生市场:干细胞各类型，各治疗法，各终端用户，各地区-规模，占有率，展望，机会分析，2023年～2030年

Stem Cell Cartilage Regeneration Market, by Stem Cell Type, by Treatment, By End User and by Region, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年04月21日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在软骨再生中，干细胞具有多重分化和自我复製的潜力，使其成为用作种子细胞的理想选择。不断成长的再生医学产业和在开发各种类型的细胞疗法时对干细胞的需求不断增加，预计将在预测期内推动市场的成长。间充质干细胞是软骨再生领域应用最为广泛的干细胞。此外，成体干细胞具有分化成软骨、骨骼、脂肪或软组织的潜力。基于干细胞的治疗已成为软骨再生功能替代的重点。可以透过微创方法从脂肪组织和骨髓中提取成体干细胞。脂肪来源的干细胞表现出增强的分化为软骨的能力，并且发现其数量高于骨髓。

增加的研发活动将在预测期内推动市场，例如，2020年8月，资料发表在斯坦福医学杂誌上，据称，斯坦福大学医学院的研究人员发现了一种再生方法，在小鼠和人体组织中，关节中的软骨垫。斯坦福大学的研究人员弄清楚瞭如何透过首先对关节组织造成轻微损伤来再生关节软骨，然后在损伤癒合时使用化学讯号来引导骨骼干细胞的生长。

本报告对全球干细胞软骨再生市场进行了深入分析，并提供了预测期(2023-2030年)的市场规模(百万美元)和年复合成长率(CAGR%)，以2022年为基数年

In cartilage regeneration, stem cells have the potential for multiple differentiation and self-replication, making them an ideal choice for use as seed cells. The growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies are expected to drive the growth of the market over the forecast period. Mesenchymal stem cells are the most widely applied stem cells in the field of cartilage regeneration. Furthermore, adult stem cells have the potential to differentiate into cartilage, bone, fat or soft tissue. Stem cell-based therapy has become a key focus in the functional replacement of cartilage regeneration. Adult stem cells can be extracted by minimally invasive methods from fat tissue and bone marrow. Fat-derived stem cells exhibit an enhanced ability to differentiate into cartilage and are found in higher numbers than bone marrow.

Market Dynamics

Increasing research and development activities is expected to drive the market over the forecast period for instance, in August 2020, data was published in the Stanford Medicine journal, according to that, researchers at the Stanford University School of Medicine have discovered a way to regenerate, in mice and human tissue, the cushion of cartilage found in joints. The Stanford researchers figured out how to regrow articular cartilage by first causing slight injury to the joint tissue, then using chemical signals to steer the growth of skeletal stem cells as the injuries heal.

Key features of the study:

This report provides an in-depth analysis of the global stem cell cartilage regeneration market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global stem cell cartilage regeneration market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation. Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global stem cell cartilage regeneration market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell cartilage regeneration market

Detailed Segmentation:

Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type :
- Hematopoietic Stem Cells (HSCs)
- Pluripotent Stem Cells (iPSC/ESCs)
- Mesenchymal Stem Cells (MSCs)
Global Stem Cell Cartilage Regeneration Market, By Treatment:
- Microfracture
- Osteochondral Transplant
- Autologous Chondrocyte Implantation
- Stem Cell Injections
Global Stem Cell Cartilage Regeneration Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
Global Stem Cell Cartilage Regeneration Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Theracell Advanced Biotechnology Ltd *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Orthocell Ltd.
- Xintela AB
- CellGenix GmbH
- Merck KGaA
- Osiris Therapeutics, Inc.
- BioTissue SA
- Vericel Corporation

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Stem Cell Type
- Market Snapshot, By Treatment
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launch
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions

4. Global Stem Cell Cartilage Regeneration Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hematopoietic Stem Cells (HSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pluripotent Stem Cells (iPSC/ESCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Mesenchymal Stem Cells (MSCs)
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Stem Cell Cartilage Regeneration Market, By Treatment, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Microfracture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Osteochondral Transplant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Autologous Chondrocyte Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Stem Cell Injections
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

7. Global Stem Cell Cartilage Regeneration Market, By End User, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-O-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$) Million)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$) Million)

8. Global Stem Cell Cartilage Regeneration Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Theracell Advanced Biotechnology Ltd*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Orthocell Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Xintela AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CellGenix GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Osiris Therapeutics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BioTissue SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

干细胞软骨再生市场:干细胞各类型，各治疗法，各终端用户，各地区-规模，占有率，展望，机会分析，2023年～2030年

Stem Cell Cartilage Regeneration Market, by Stem Cell Type, by Treatment, By End User and by Region, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

目录

第1章调查目的与前提条件

第2章市场展望

第3章市场动态，法规，趋势分析

第4章干细胞软骨再生的全球市场- 冠状病毒(COVID-19)的大流行的影响

第5章干细胞软骨再生的全球市场，各干细胞类型，2017年～2030年

第6章干细胞软骨再生的全球市场，各治疗法，2017年～2030年

第7章干细胞软骨再生的全球市场，各终端用户，2017年～2030年

第8章干细胞软骨再生的全球市场，各地区，2017年～2030年

第9章竞争情形

第10章 Section